Literature DB >> 11864781

Supplementation with antioxidant vitamins prevents oxidative modification of DNA in lymphocytes of HIV-infected patients.

Pawel Jaruga1, Barbara Jaruga, Daniel Gackowski, Anita Olczak, Waldemar Halota, Malgorzata Pawlowska, Ryszard Olinski.   

Abstract

There is evidence suggesting that patients infected with human immunodeficiency virus (HIV) are under chronic oxidative stress. In the present study, the level of oxidatively modified bases in lymphocyte DNA and some other parameters of oxidative stress were measured in HIV-infected patients (n = 30), as well as in control groups (10 healthy volunteers and 15 HIV-seronegative injected drug users). Additional experiments were conducted using lymphocyte DNA samples from asymptomatic seropositive, HIV-infected patients who were supplemented with antioxidant vitamins A, C, and E or received placebo. Significant increases in the amount of the modified DNA bases were observed in HIV-infected patients when compared with the control group. The concentration of thiobarbituric acid reactive substances (TBARS) was higher and activities of antioxidant enzymes (superoxide dismutase and catalase) were lower in the group of HIV-infected patients in comparison to the control group. Vitamin supplementation resulted in the significant decrease in the levels of all modified DNA bases when compared to the patients who received placebo. The reduction of TBARS and the restoration of the activity of the enzymes were also observed. Our data suggest that people infected with HIV can benefit from treatment with antioxidant vitamins.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11864781     DOI: 10.1016/s0891-5849(01)00821-8

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  21 in total

1.  Clinical factors associated with plasma F2-isoprostane levels in HIV-infected adults.

Authors:  Leigh Anne Redhage; Ayumi Shintani; David W Haas; Nkiruka Emeagwali; Milica Markovic; Ikwo Oboho; Christopher Mwenya; Husamettin Erdem; Edward P Acosta; Jason D Morrow; Todd Hulgan
Journal:  HIV Clin Trials       Date:  2009 May-Jun

2.  Involvement of oxidatively damaged DNA and repair in cancer development and aging.

Authors:  Barbara Tudek; Alicja Winczura; Justyna Janik; Agnieszka Siomek; Marek Foksinski; Ryszard Oliński
Journal:  Am J Transl Res       Date:  2010-05-15       Impact factor: 4.060

3.  Immunoneuropathogenesis of HIV-1 clades B and C: role of redox expression and thiol modification.

Authors:  Thangavel Samikkannu; Kurapati V K Rao; Sudhessh Pilakka Kanthikeel; Venkata Subba Rao Atluri; Marisela Agudelo; Upal Roy; Madhavan P N Nair
Journal:  Free Radic Biol Med       Date:  2014-01-27       Impact factor: 7.376

Review 4.  Nutrition and disease progression pre-highly active antiretroviral therapy (HAART) and post-HAART: can good nutrition delay time to HAART and affect response to HAART?

Authors:  Aditya Chandrasekhar; Amita Gupta
Journal:  Am J Clin Nutr       Date:  2011-11-16       Impact factor: 7.045

5.  Effects of basal level of antioxidants on oxidative DNA damage in humans.

Authors:  Marek Foksinski; Daniel Gackowski; Rafal Rozalski; Agnieszka Siomek; Jolanta Guz; Anna Szpila; Tomasz Dziaman; Ryszard Olinski
Journal:  Eur J Nutr       Date:  2007-01-30       Impact factor: 5.614

6.  Genetic variants in nuclear-encoded mitochondrial genes influence AIDS progression.

Authors:  Sher L Hendrickson; James A Lautenberger; Leslie Wei Chinn; Michael Malasky; Efe Sezgin; Lawrence A Kingsley; James J Goedert; Gregory D Kirk; Edward D Gomperts; Susan P Buchbinder; Jennifer L Troyer; Stephen J O'Brien
Journal:  PLoS One       Date:  2010-09-21       Impact factor: 3.240

7.  Effect of high-dose vs standard-dose multivitamin supplementation at the initiation of HAART on HIV disease progression and mortality in Tanzania: a randomized controlled trial.

Authors:  Sheila Isanaka; Ferdinand Mugusi; Claudia Hawkins; Donna Spiegelman; James Okuma; Said Aboud; Chalamilla Guerino; Wafaie W Fawzi
Journal:  JAMA       Date:  2012-10-17       Impact factor: 56.272

8.  Mitochondrial haplogroups are associated with risk of neuroretinal disorder in HIV-positive patients.

Authors:  Sher L Hendrickson; Douglas A Jabs; Mark Van Natta; Richard Alan Lewis; Douglas C Wallace; Stephen J O'Brien
Journal:  J Acquir Immune Defic Syndr       Date:  2010-04-01       Impact factor: 3.731

9.  Mitochondrial DNA haplogroups influence AIDS progression.

Authors:  Sher L Hendrickson; Holli B Hutcheson; Eduardo Ruiz-Pesini; Jason C Poole; James Lautenberger; Efe Sezgin; Lawrence Kingsley; James J Goedert; David Vlahov; Sharyne Donfield; Douglas C Wallace; Stephen J O'Brien
Journal:  AIDS       Date:  2008-11-30       Impact factor: 4.177

10.  Reconciling conflicting clinical studies of antioxidant supplementation as HIV therapy: a mathematical approach.

Authors:  Rolina D van Gaalen; Lindi M Wahl
Journal:  BMC Public Health       Date:  2009-11-18       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.